Diagnostic Performance of the ICD-10 Code K76.82 for Hepatic Encephalopathy in Patients With Cirrhosis.
Document Type
Article
Publication Date
2-1-2024
Publication Title
The American journal of gastroenterology
Abstract
INTRODUCTION: Hepatic encephalopathy (HE) is prevalent and is associated with increased morbidity and mortality among patients with cirrhosis. On October 1, 2022, a new, specific International Classification of Diseases-10 code for HE, K76.82, was introduced. We aimed to analyze the diagnostic accuracy of K76.82.
METHODS: Diagnostic performance of K76.82 for HE (sensitivity, specificity, positive predictive ratio, and negative predictive ratio) was evaluated in 2 large health systems compared with lactulose, rifaximin, and K72.90.
RESULTS: A total of 2,483 patients were analyzed. The combination term "lactulose or rifaximin" showed the highest sensitivity of >98% while K76.82 demonstrated a specificity of >87% in all cohorts.
DISCUSSION: Although K76.82 is promising, the combination term "lactulose or rifaximin" identified patients with HE more accurately.
Volume
119
Issue
2
First Page
364
Last Page
366
Recommended Citation
Ozturk NB, Jamil LH, Tapper EB. Diagnostic performance of the ICD-10 code K76.82 for hepatic encephalopathy in patients with cirrhosis. Am J Gastroenterol. 2024 Feb 1; 119(2); 364-366. doi: 10.14309/ajg.0000000000002560 PMID: 37830544
DOI
10.14309/ajg.0000000000002560
ISSN
1572-0241
PubMed ID
37830544